Thermo Fisher Jan 30, 2026 Thermo Fisher: The Market Is Missing The Point, This Pullback Is A Buy (Rating Update) - Seeking Alpha
BioPharma Dive Jan 30, 2026 AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC
FierceBiotech Jan 30, 2026 Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Agilent Jan 30, 2026 Is Now The Time To Look At Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
Endpoints News Jan 30, 2026 Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo
10x Genomics Blog Jan 30, 2026 Ex-CEO Behind Bars, 10x’s Clinical Ambitions, Pharma’s AI Gambit - Genetic Engineering and Biotechnology News
10x Genomics Blog Jan 30, 2026 Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss - Nature
Agilent Jan 30, 2026 Mutual of America Capital Management LLC Sells 12,121 Shares of Agilent Technologies, Inc. $A - MarketBeat
Harvard Bioscience Jan 30, 2026 Life sciences instrument manufacturer closing Mass. facility - The Business Journals